Premier Invests In Exela To Procure Shortage-Hit Generic Injectables

Participating Premier Health Systems Sign Multi-Year Purchasing Commitments

As hospital drug shortages continue to bite in the US, a group purchasing organization has invested in generic injectables specialist Exela Pharma Sciences to garner uninterrupted supply of 19 pharmaceutical products.

Supply Chain
The deal will secure vital supply of critical medicines • Source: Alamy

More from Deals

More from Business